John Theurer Cancer Center at the Hackensack University Medical Center

Hackensack, New Jersey 07601

0 studies enrolling now · 2 studies all time

What they study most

Acute Myeloid Leukemia, Glioblastoma, IDH-wildtype

Studies at this site

• Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter — Stopped early
• A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia — Completed